Actively Recruiting
Effects of CBT-I on Impulsivity and Risk Taking in Youths With Insomnia
Led by The University of Hong Kong · Updated on 2026-02-10
124
Participants Needed
1
Research Sites
127 weeks
Total Duration
On this page
Sponsors
T
The University of Hong Kong
Lead Sponsor
C
Chinese University of Hong Kong
Collaborating Sponsor
AI-Summary
What this Trial Is About
Insomnia is prevalent in adolescents. Impulsive behaviours and excessive risk-taking have been linked to the manifestation of psychopathology in youths. Previous research based on behavioural and neurophysiological measures has found that individuals with insomnia demonstrated impaired inhibitory control, which is associated with detrimental outcomes such as substance abuse and self-harm. Existing evidence has shown some positive effects of cognitive behavioural therapy for insomnia (CBT-I) on insomnia symptoms and daytime functioning in youths. Given the link between insomnia and impulsivity reported in previous research, and sleep as a highly modifiable factor, we are conducting this randomised controlled trial to examine the impact of CBT-I in improving impulsivity and risk-taking in youth with insomnia.
CONDITIONS
Official Title
Effects of CBT-I on Impulsivity and Risk Taking in Youths With Insomnia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Chinese individuals aged 12 to 24 years old
- Written informed consent provided by participant and parent/guardian if under 18
- Willing to comply with the study protocol
- Diagnosed with insomnia disorder according to DSM-V criteria
- Insomnia Severity Index (ISI) score of 9 or higher
You will not qualify if you...
- Current diagnosis of substance abuse or dependence
- History of manic or hypomanic episodes, schizophrenia spectrum disorders, neurodevelopmental disorders, organic mental disorders, or intellectual disabilities
- Medical conditions known to affect sleep quality (e.g., eczema, gastro-oesophageal reflux disease)
- Clinically diagnosed sleep disorders other than insomnia (e.g., narcolepsy, sleep-disordered breathing, restless leg syndrome)
- Regular use of medications affecting sleep (including hypnotics, steroids, melatonin, Traditional Chinese Medicine)
- Clinically significant suicidality (suicidal ideation with plan or attempt)
- Currently receiving psychological treatment for insomnia
- Hearing or speech deficits
- Night shift work
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sleep Research Clinic and Laboratory, Department of Psychology, The University of Hong Kong
Hong Kong, Hong Kong
Actively Recruiting
Research Team
S
Shirley Xin LI, DClinPsy, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here